We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+10.56%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$12.2B
AUM Growth
+$1.03B
Cap. Flow
+$49.2M
Cap. Flow %
0.4%
Top 10 Hldgs %
25.44%
Holding
2,628
New
63
Increased
565
Reduced
814
Closed
130

Sector Composition

Rank Sector Weight
1 Technology 22.34%
2 Healthcare 12.24%
3 Financials 12%
4 Consumer Discretionary 11.44%
5 Industrials 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HWM icon
726
Howmet Aerospace
HWM
$111B
$2.7M 0.02%
84,949
-2,237
-3% -$68.9K
RCM
727
DELISTED
R1 RCM Inc. Common Stock
RCM
$2.7M 0.02%
106,051
+268
+0.3% +$6.42K
CATY icon
728
Cathay General Bancorp
CATY
$4.31B
$2.7M 0.02%
62,854
-2,027
-3% -$87.3K
XRAY icon
729
Dentsply Sirona
XRAY
$2.26B
$2.69M 0.02%
48,297
-1,063
-2% -$58.5K
OMCL icon
730
Omnicell
OMCL
$1.7B
$2.69M 0.02%
14,912
MZTI
731
The Marzetti Company
MZTI
$3.24B
$2.68M 0.02%
16,202
+78
+0.5% +$12.8K
CBT icon
732
Cabot Corp
CBT
$4.44B
$2.67M 0.02%
47,542
+240
+0.5% +$13.2K
PNR icon
733
Pentair
PNR
$10.5B
$2.67M 0.02%
36,560
-900
-2% -$66.3K
MSA icon
734
Mine Safety
MSA
$7.31B
$2.67M 0.02%
17,670
+161
+0.9% +$24.2K
RAMP icon
735
LiveRamp
RAMP
$2.3B
$2.66M 0.02%
55,502
+368
+0.7% +$18.5K
LEG icon
736
Leggett & Platt
LEG
$1.31B
$2.66M 0.02%
64,636
+34,530
+115% +$1.5M
BHVN
737
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.66M 0.02%
19,281
SRCL
738
DELISTED
Stericycle Inc
SRCL
$2.66M 0.02%
44,518
+391
+0.9% +$24.5K
CDP icon
739
COPT Defense Properties
CDP
$4.23B
$2.65M 0.02%
94,793
+468
+0.5% +$12.9K
CC icon
740
Chemours
CC
$2.29B
$2.65M 0.02%
78,973
-373
-0.5% -$11.6K
ACHC icon
741
Acadia Healthcare
ACHC
$2.88B
$2.65M 0.02%
43,584
+413
+1% +$24.6K
FLO icon
742
Flowers Foods
FLO
$1.58B
$2.65M 0.02%
96,298
+674
+0.7% +$17.4K
CW icon
743
Curtiss-Wright
CW
$25.6B
$2.64M 0.02%
19,016
-625
-3% -$82.5K
ALLE icon
744
Allegion
ALLE
$13.9B
$2.62M 0.02%
19,816
-441
-2% -$57.7K
BCO icon
745
Brink's
BCO
$4.68B
$2.62M 0.02%
39,931
-1,324
-3% -$85.3K
WRK
746
DELISTED
WestRock Company
WRK
$2.62M 0.02%
58,992
-1,313
-2% -$61.8K
CVLT icon
747
Commault Systems
CVLT
$6.03B
$2.61M 0.02%
37,928
+17
+0% +$1.16K
FOXA icon
748
Fox Class A
FOXA
$27B
$2.61M 0.02%
70,776
-2,267
-3% -$89.3K
CTXS
749
DELISTED
Citrix Systems Inc
CTXS
$2.61M 0.02%
27,555
-502
-2% -$45.9K
BYD icon
750
Boyd Gaming
BYD
$6.02B
$2.61M 0.02%
39,744
+388
+1% +$24.6K

Similar funds

MetLife Investment Management's Q4 2021 Portfolio in Review

As of Q4 2021, MetLife Investment Management held 2,628 positions worth $12.2B, up 9.2% from $11.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management's Q4 2021 filing shows 63 new, 565 increased, 814 reduced and 130 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M. The largest sale was Enterprise Products Partners, an estimated $31.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q4 2021 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,855,000 shares worth $378M.
  • MetLife Investment Management added most to iShares Russell 2000 ETF in Q4 2021, an estimated $14.1M increase.
  • MetLife Investment Management's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $31.2M.
  • MetLife Investment Management fully exited Enterprise Products Partners in Q4 2021, selling an estimated $31.9M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $12.2B portfolio in Q4 2021.
  • MetLife Investment Management opened 63 new positions and closed 130 in Q4 2021.
  • MetLife Investment Management's portfolio value rose 9.2% quarter-over-quarter to $12.2B.

Based on MetLife Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.